Ray Kurzweil joins Subsense’s push for a brain interface delivered through the nose

Neurotech startup Subsense has appointed futurist Ray Kurzweil as an advisor to help develop a nasal-delivered nanoparticle brain interface. The technology, which aims to read and stimulate neurons without implants, remains in the preclinical stage with clinical pilots targeted for 2027–2029.
Why it matters
This represents a significant, albeit speculative, advancement in non-invasive brain-computer interface technology.
Ray Kurzweil joins Subsense as an advisor as it pursues a nasal nanoparticle brain interface, with human safety and reliable function still to be proven.
Ray Kurzweil is joining neurotech startup Subsense as a product and vision advisor as the company develops an experimental brain interface that would deliver nanoparticles through the nose. The proposed system pairs those particles with an external wearable to read neural activity and stimulate neurons while potentially avoiding electrode implantation.
As reported in The Rundown’s September 4 newsletter , Subsense remained preclinical, had raised $27 million, and was targeting clinical pilots in 2027–29. Kurzweil’s appointment brings a prominent AI futurist to the project, but the central question remains whether the technology can work safely and reliably in people.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in